BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22450525)

  • 1. [Is there a benefit to continue pap smear screening for cervical cancer after 65 years of age? A retrospective study on 53,644 women].
    Meyer R; Lemay AL; Guy X; Giraud C; Mathevet P; Flori M
    Bull Cancer; 2012 Apr; 99(4):409-15. PubMed ID: 22450525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of prevention: downstream consequences of Pap smear testing in the elderly.
    Sirovich BE; Gottlieb DJ; Fisher ES
    J Med Screen; 2003; 10(4):189-95. PubMed ID: 14738656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pap Smear after 65 years].
    Enderle I; Le Baccon FA; Pinsard M; Joueidi Y; Lavoué V; Levêque J; Nyangoh Timoh K
    Gynecol Obstet Fertil Senol; 2017 Sep; 45(9):478-485. PubMed ID: 28864050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with Pap smear screening among French women visiting a general practitioner in the Rhône-Alpes region.
    Oussaid N; Lutringer-Magnin D; Barone G; Haesebaert J; Lasset C
    Rev Epidemiol Sante Publique; 2013 Oct; 61(5):437-45. PubMed ID: 24012357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical Papanicolaou Smears in Hematopoietic Stem Cell Transplant Recipients: High Prevalence of Therapy-Related Atypia during the Acute Phase.
    Yu SC; Huang HH; Li CC; Tang JL; Lee YH; Mao TL; Kuo KT; Lin CT; Liu JH; Ko BS; Yao M
    Biol Blood Marrow Transplant; 2017 Aug; 23(8):1367-1373. PubMed ID: 28450182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No increased risk for cervical cancer after a broader definition of a negative Pap smear.
    Rebolj M; van Ballegooijen M; van Kemenade F; Looman C; Boer R; Habbema JD
    Int J Cancer; 2008 Dec; 123(11):2632-5. PubMed ID: 18767046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pap smear, an important screening tool to detect precancerous stage of carcinoma of cervix.
    Haider G; Parveen Z; Anjum F; Munir A
    J Ayub Med Coll Abbottabad; 2013; 25(1-2):26-7. PubMed ID: 25098046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of 114 abnormal Pap smear follow-up in ambulatory care.].
    Peccatte É; Vallée J; Trombert B; Savall A
    Sante Publique; 2018; 30(4):527-532. PubMed ID: 30540142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary comparison of papanicolaou smear and speculoscopy for assessing cervical cancer precursor lesions in pregnant adolescents.
    Shulman LP; Klett CC; Phillips OP
    J Pediatr Adolesc Gynecol; 1999 May; 12(2):78-82. PubMed ID: 10326192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pap test--with or without vaginal smear?
    Milicić-Juhas V; Perić M; Pajtler M; Prvulović I; Curzik D
    Coll Antropol; 2010 Mar; 34(1):69-74. PubMed ID: 20437636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pap smear screening, pap smear abnormalities and psychosocial risk factors among women in a residential alcohol and drug rehabilitation facility.
    Soccio J; Brown M; Comino E; Friesen E
    J Adv Nurs; 2015 Dec; 71(12):2858-66. PubMed ID: 26279461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan.
    Sung HY; Kearney KA; Miller M; Kinney W; Sawaya GF; Hiatt RA
    Cancer; 2000 May; 88(10):2283-9. PubMed ID: 10820350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of histiocyte detection in Pap smears for predicting endometrial pathology. An institutional experience.
    Nassar A; Fleisher SR; Nasuti JF
    Acta Cytol; 2003; 47(5):762-7. PubMed ID: 14526675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gynecological care of elderly women. Another look at Papanicolaou smear testing.
    Mandelblatt J; Gopaul I; Wistreich M
    JAMA; 1986 Jul; 256(3):367-71. PubMed ID: 3723723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of an extended free-of-fee strategy on the rate of cervical Papanicolaou smear screening in Israel.
    Froimovici M; Sulema V; Lurie S
    Int J Gynaecol Obstet; 2013 Feb; 120(2):127-30. PubMed ID: 23151372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of and attitudes and knowledge about pap smears among women in Kuwait.
    El-Hammasi K; Samir O; Kettaneh S; Al-Fadli A; Thalib L
    J Womens Health (Larchmt); 2009 Nov; 18(11):1825-32. PubMed ID: 19951218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer screening among women without a cervix.
    Sirovich BE; Welch HG
    JAMA; 2004 Jun; 291(24):2990-3. PubMed ID: 15213211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of cervical cancer after a negative Pap smear.
    Viikki M; Pukkala E; Hakama M
    J Med Screen; 1999; 6(2):103-7. PubMed ID: 10444730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interval between two smear tests for cervical cancer screening and characteristics of women with a short interval: Study in the department of Isère].
    Caporossi A; Olicard C; Seigneurin A; Garnier A
    Rev Epidemiol Sante Publique; 2019 May; 67(3):143-147. PubMed ID: 30981595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.